Tags

Type your tag names separated by a space and hit enter

Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers.
J Psychoactive Drugs. 2017 Apr-Jun; 49(2):111-121.JP

Abstract

The Affordable Care Act (ACA) has been heralded as a major policy change that is expected to transform the delivery of substance use disorder (SUD) treatment. Few studies have reported on the perceived impacts of ACA from the perspectives of SUD treatment providers, such as physicians who prescribe buprenorphine to patients with opioid use disorder. The present study describes buprenorphine prescribers' perceptions regarding impacts of the ACA on the delivery of buprenorphine and examines whether state-level approaches to implementing ACA are associated with its perceived impacts. Data are drawn from a national sample of current buprenorphine prescribers (n = 1,174) who were surveyed by mail. On average, buprenorphine prescribers reported ambivalence regarding the impacts of the ACA, as indicated by a mean of 2.75 (SD = 0.69) on a scale that ranged from 1 ("strongly disagree") to 5 ("strongly agree"). A multi-level mixed-effects regression model indicated that physicians practicing in states that were supportive of ACA, as indicated by adopting both the Medicaid expansion and implementing a state-based health insurance exchange, had more positive perceptions of the ACA than physicians in states that had declined both of these policies. This study suggests that state approaches to ACA may be associated with varied impacts.

Authors+Show Affiliations

a Associate Professor, Center on Drug and Alcohol Research , University of Kentucky , Lexington , KY , USA. b Associate Professor, Department of Behavioral Science , University of Kentucky , Lexington , KY , USA.b Associate Professor, Department of Behavioral Science , University of Kentucky , Lexington , KY , USA.

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

28296579

Citation

Knudsen, Hannah K., and Jamie L. Studts. "Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers." Journal of Psychoactive Drugs, vol. 49, no. 2, 2017, pp. 111-121.
Knudsen HK, Studts JL. Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers. J Psychoactive Drugs. 2017;49(2):111-121.
Knudsen, H. K., & Studts, J. L. (2017). Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers. Journal of Psychoactive Drugs, 49(2), 111-121. https://doi.org/10.1080/02791072.2017.1295335
Knudsen HK, Studts JL. Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers. J Psychoactive Drugs. 2017 Apr-Jun;49(2):111-121. PubMed PMID: 28296579.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers. AU - Knudsen,Hannah K, AU - Studts,Jamie L, Y1 - 2017/03/15/ PY - 2017/3/16/pubmed PY - 2018/3/10/medline PY - 2017/3/16/entrez KW - Affordable Care Act KW - buprenorphine KW - health reform KW - physician survey KW - substance use disorder treatment delivery SP - 111 EP - 121 JF - Journal of psychoactive drugs JO - J Psychoactive Drugs VL - 49 IS - 2 N2 - The Affordable Care Act (ACA) has been heralded as a major policy change that is expected to transform the delivery of substance use disorder (SUD) treatment. Few studies have reported on the perceived impacts of ACA from the perspectives of SUD treatment providers, such as physicians who prescribe buprenorphine to patients with opioid use disorder. The present study describes buprenorphine prescribers' perceptions regarding impacts of the ACA on the delivery of buprenorphine and examines whether state-level approaches to implementing ACA are associated with its perceived impacts. Data are drawn from a national sample of current buprenorphine prescribers (n = 1,174) who were surveyed by mail. On average, buprenorphine prescribers reported ambivalence regarding the impacts of the ACA, as indicated by a mean of 2.75 (SD = 0.69) on a scale that ranged from 1 ("strongly disagree") to 5 ("strongly agree"). A multi-level mixed-effects regression model indicated that physicians practicing in states that were supportive of ACA, as indicated by adopting both the Medicaid expansion and implementing a state-based health insurance exchange, had more positive perceptions of the ACA than physicians in states that had declined both of these policies. This study suggests that state approaches to ACA may be associated with varied impacts. SN - 2159-9777 UR - https://www.unboundmedicine.com/medline/citation/28296579/Perceived_Impacts_of_the_Affordable_Care_Act:_Perspectives_of_Buprenorphine_Prescribers_ L2 - https://www.tandfonline.com/doi/full/10.1080/02791072.2017.1295335 DB - PRIME DP - Unbound Medicine ER -